Unknown OBSERVATIONAL NCT03495050

BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience. (BIVOLUTX)

Sponsor: Clinique Pasteur

Interventions Transcatheter Aortic Valve Implantation

Updated 8 times since 2018 Last updated: Jun 10, 2018 Started: Feb 21, 2018 Primary completion: May 31, 2019 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03495050, this observational or N/A phase trial focuses on Bicuspid Aortic Valve and remains ongoing. Sponsored by Clinique Pasteur, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jul 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Feb 2020 — Jul 2020 [monthly]

Recruiting

▶ Show 3 earlier versions

Jul 2018 — Feb 2020 [monthly]

Recruiting

Status: Active Not Recruiting → Recruiting
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting
May 2018 — Jun 2018 [monthly]

Active Not Recruiting

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinique Pasteur

Data source: Clinique Pasteur

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France